Forte Biosciences Inc Financial Flexibility Index
Forte Biosciences Inc financial flexibility index. Forte Biosciences Inc (FBRX) has a Financial Flexibility Index of -1.07x as of September 2025. Free cash flow of $-13.95 Million (operating CF $-14.00 Million minus capex $55.00K) represents -1% of total liabilities ($12.99 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Forte Biosciences Inc (2015–2024)
Financial flexibility index of Forte Biosciences Inc from 2015 to 2024. Historical Financial Flexibility Index trend for Forte Biosciences Inc across 10 annual periods. Explore FBRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Forte Biosciences Inc Financial Flexibility Index by Year (2015–2024)
Forte Biosciences Inc financial flexibility index by year from 2015 to 2024. Year-by-year free cash flow to debt coverage for Forte Biosciences Inc. For the full cash flow conversion analysis, see cash flow conversion of Forte Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.38x | $-30.71 Million | $-30.75 Million | $9.08 Million | ▲ +56.7% |
| 2023 | -7.81x | $-28.62 Million | $-28.71 Million | $3.67 Million | ▼ -203.2% |
| 2022 | -2.57x | $-8.19 Million | $-8.19 Million | $3.18 Million | ▲ +72.8% |
| 2021 | -9.45x | $-16.62 Million | $-16.68 Million | $1.76 Million | ▼ -15.9% |
| 2020 | -8.16x | $-18.42 Million | $-18.42 Million | $2.26 Million | ▼ -497.7% |
| 2019 | -1.36x | $-2.61 Million | $-2.77 Million | $1.91 Million | ▼ -88.7% |
| 2018 | -0.72x | $-32.50 Million | $-34.47 Million | $44.94 Million | ▲ +50.2% |
| 2017 | -1.45x | $-30.48 Million | $-31.13 Million | $20.99 Million | ▼ -41.9% |
| 2016 | -1.02x | $-29.01 Million | $-29.54 Million | $28.36 Million | ▼ -13.5% |
| 2015 | -0.90x | $-20.81 Million | $-21.04 Million | $23.09 Million | — |